Prothena Corporation Email Format

Biotechnology ResearchLeinster, Ireland51-200 Employees

Prothena Corporation is a late-stage clinical biotechnology company focused on protein dysregulation and the development of therapies for neurodegenerative and rare peripheral amyloid diseases. Its work draws on insights into neurological dysfunction and misfolded proteins to create treatments aimed at directly targeting pathogenic proteins and altering disease progression. Its portfolio targets conditions that affect millions of people and their families worldwide. The company is based in Dublin, Leinster.

In March 2026, Prothena announced the development of its CYTOPE technology to address intracellular disease pathways in both the brain and the periphery. This focus aligns with ongoing work to pursue novel therapeutic approaches for intracellular pathways in the brain and peripheral tissues.

Get verified Prothena Corporation emails free

Company overview Employee directory